Iveda Solutions Inc Dossier - Source-backed chat

Iveda Solutions Inc

IVDANASDAQ

SectorInformation Technology

IndustrySystems Software

Beta (adjusted)0.98

Intrinsic Value

No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference.

Market Price $0.30Price as of 1 Oct 2026

Data confidence Sign in to view data confidence

Market Cap $3.7M

Enterprise Value −$694.5K

Shares Outstanding 11.2M diluted

Next Earnings Date16 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Iveda Solutions, Inc. (IVDA) is positioned at the intersection of AI-driven video analytics, smart city technologies, and IoT platforms. While the company continues to innovate with new product rollouts (such as Sleep Sense for IvedaCare and real-time zero-shot AI detection) and is expanding its geographic footprint into Europe and Egypt, it remains constrained by persistent operating losses, high customer concentration in Taiwan, and significant dilution from recent equity raises. Furthermore, the company is currently under a Nasdaq minimum bid price deficiency notice with a cure deadline of September 2, 2026. Given these mixed dynamics, a Hold recommendation is warranted until the company demonstrates a clear path to self-sustaining profitability and resolves its listing compliance issues.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$0.1520%

Taiwan project revenue slows down, and international expansion fails to gain meaningful traction. Ongoing cash burn depletes the company's cash reserves faster than anticipated, leading to further dilutive equity offerings. The company fails to regain Nasdaq compliance and is delisted to the OTC market, severely impacting liquidity and valuation.

Base CaseCentral scenario

$0.5055%

Iveda maintains modest revenue growth driven primarily by Taiwan government projects and incremental international sales. Operating losses narrow gradually, but the company continues to burn cash from operations, relying on its existing cash cushion of $5.7 million. The company may require a reverse stock split to regain Nasdaq minimum bid price compliance before the September 2, 2026 deadline.

Bull CaseUpside scenario

$1.5025%

Rapid adoption of Iveda's proprietary AI video search and IoT platforms drives high-margin recurring SaaS revenue. Successful expansion in Europe via the Madrid operations center and local manufacturing in Egypt significantly reduces customer concentration. The company regains Nasdaq compliance organically, and gross margins continue to expand, leading to profitability.

Scenarios reflect our research view at the research date.

Key Investment Merits

Proprietary, patented AI video analytics and IoT platform technology with global applications.
Expanding product portfolio including contactless health monitoring (Sleep Sense) and zero-shot AI detection.
Geographic diversification efforts with new operations in Spain and manufacturing partnerships in Egypt.
Improved gross margins and narrowed net losses in recent quarters.

Key Investment Risks

Persistent history of operating losses and accumulated deficit of approximately $56 million.
High customer concentration, with a significant portion of revenues derived from a few Taiwan government contracts.
Nasdaq delisting risk due to failure to maintain the $1.00 minimum bid price.
Material weaknesses in internal controls over financial reporting and disclosure controls.
Substantial shareholder dilution from recent equity and warrant offerings.

Thesis Invalidation Triggers

Delisting from the Nasdaq Capital Market to the OTC markets.
Loss of key Taiwan government contracts without offsetting international revenue.
Rapid depletion of the cash runway below 6 months of operating expenses.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.